Avadel Pharmaceuticals (AVDL) SEC Filings & 10K Form

$18.20
+0.11 (+0.61%)
(As of 10:15 AM ET)

Recent Avadel Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/15/2024
6:00 AM
Avadel Pharmaceuticals (Filer)
Form 8-A12B
04/15/2024
6:01 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2024
5:28 AM
Avadel Pharmaceuticals (Issuer)
Kim Richard J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
5:35 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2024
5:24 AM
Avadel Pharmaceuticals (Issuer)
Divis Gregory J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
5:26 AM
Avadel Pharmaceuticals (Issuer)
MCHUGH THOMAS S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
6:11 AM
Avadel Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G/A
02/13/2024
4:54 PM
Avadel Pharmaceuticals (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G/A
02/13/2024
8:40 AM
Avadel Pharmaceuticals (Subject)
Polar Capital Holdings Plc (Filed by)
Form SC 13G
02/12/2024
7:20 AM
Avadel Pharmaceuticals (Subject)
KOTLER KEVIN (Filed by)
Form SC 13G/A
01/16/2024
3:36 PM
Avadel Pharmaceuticals (Issuer)
MCHUGH THOMAS S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
6:20 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2023
3:15 PM
Avadel Pharmaceuticals (Issuer)
McCamish Mark Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2023
1:54 PM
Avadel Pharmaceuticals (Subject)
McCamish Mark Anthony (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2023
8:25 AM
Avadel Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2023
6:09 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/01/2023
8:30 PM
Avadel Pharmaceuticals (Issuer)
Glass Geoffrey Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2023
8:30 PM
Avadel Pharmaceuticals (Issuer)
Palczuk Linda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2023
4:56 PM
Avadel Pharmaceuticals (Issuer)
MCHUGH THOMAS S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2023
3:00 PM
Avadel Pharmaceuticals (Issuer)
Glass Geoffrey Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2023
2:50 PM
Avadel Pharmaceuticals (Subject)
McCamish Mark Anthony (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/10/2023
5:45 PM
Avadel Pharmaceuticals (Issuer)
Divis Gregory J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2023
2:25 PM
Avadel Pharmaceuticals (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G
08/09/2023
8:26 AM
Avadel Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2023
6:37 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/03/2023
3:15 PM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/03/2023
6:30 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2023
8:30 PM
Avadel Pharmaceuticals (Issuer)
Kim Richard J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2023
8:31 PM
Avadel Pharmaceuticals (Issuer)
MCHUGH THOMAS S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2023
8:29 PM
Avadel Pharmaceuticals (Issuer)
Divis Gregory J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2023
6:05 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/04/2023
3:08 PM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2023
2:16 PM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2023
3:08 PM
Avadel Pharmaceuticals (Filer)
Form DEF 14A
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:AVDL) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners